At this stage of my investment in this start-up, O
Post# of 30028
All this uplisting attempt before I believe got us into these horrible toxic series notes. The Nasdaq requirements could not be met so AMBS went trolling for cash to fatten the balance sheet. Our gamble imploded, and here we go again. And to think ESS was not even in our pocket back then. This stock has been a ride...for true. I was totally bamboozled by Lympro / Georgetown etc.
Oh well, I have averaged down and just might get our $$ back, or even thirty cents on the dollar (if this new plot works). It was all my greed and my fault that put me in this position. But I don't believe Amarantus has been honest with it's investors. But here we are *****
Aloha, BsR